Share Buyback

As Sachem Capital sets its Q1 earnings date, investors watch closely for signs of stability in the hard money lending market after a volatile period.

Following a year of record profits, Cipher Pharmaceuticals is renewing its share buyback program, signaling a strong belief that its stock is undervalued.

Facing mounting debt and a harsh market, the Canadian diamond miner sells assets to a related party and extends loans, buying just two months of time.

As explosive growth meets dry Texas landscape, a new high-tech arsenal gives firefighters a crucial edge in protecting the wildland-urban interface.

Aalberts N.V. returns to organic growth in Q1 2026, driven by its 'thrive 2030' strategy, successful acquisitions, and operational improvements.

A massive lawsuit plunged the brewer into a deep quarterly loss, overshadowing operational gains and highlighting struggles in a shifting beverage market.

The chemical giant's Q1 earnings fell year-over-year, but strong sequential growth and a "net upside" from global conflict fuel an optimistic 2026 outlook.

With record growth and raised guidance, the REIT leverages market trends and strategic partnerships to solidify its leadership in medical real estate.

Aimco declares a $1.30/share liquidating distribution. Understand the 'due bills' trading and what this means for your investment as the REIT winds down.

The energy services giant posts strong Q1 results, capitalizing on a strategic industry shift to offshore projects for enhanced energy security and profits.

The firm approved a consistent dividend and a share buyback, signaling confidence despite a reported drop in net profit that still beat forecasts.

Aker Solutions posts solid Q1 results with a massive order intake, rewarding shareholders while strategically pivoting towards emerging markets like nuclear energy.

Despite mixed Q1 results, the IoT pioneer's record-breaking orders and explosive Q2 outlook signal strong demand for its RAIN RFID technology.

Connection (CNXN) reports a 27.8% surge in Q1 net income driven by enterprise AI adoption, yet faces a steep 31% decline in public sector sales.

The insurer's Q1 net income surged 33% on a booming insurance unit, while it strategically trims its reinsurance book amid a softening market.

The company capitalized on geopolitical turmoil and strong demand to post a massive Q1 profit, while advancing its long-term low-carbon ammonia project.

Markel Group reports a Q1 loss due to market volatility, but its core insurance engine shines with a 31% profit jump and improved underwriting.

After a turbulent year, Valerio Therapeutics unveils a radical new strategy focused on its V-Body platform, a new subsidiary, and strict cost controls.

GD Culture Group launches 'Fato', an AI-powered interactive novel, in a bold pivot. Can it disrupt a growing market or will it be lost in the hype?

Anika Therapeutics posts strong Q1 results with a 13% revenue jump, but analyst caution lingers over pipeline risks and long-term sustainability.